The clinical spectrum and therapeutic challenge of eczema herpeticum

Pediatric Dermatology

Volumn 28, Issue 1, 2011, Pages 46-52

  Frisch, Stephanie ^a   Siegfried, Elaine C ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ACICLOVIR; ANTIBIOTIC AGENT; CALCINEURIN INHIBITOR; COBALT; CORTICOSTEROID; CYCLOSPORIN; DESOXIMETASONE; DICHROMATE POTASSIUM; ERGOCALCIFEROL; FAMCICLOVIR; FLUOCINONIDE; FOSCARNET; GAMMA INTERFERON; GAMMA1B INTERFERON; GANCICLOVIR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN M; METHOTREXATE; MOMETASONE FUROATE; NARCOTIC AGENT; NEOMYCIN; NICKEL; OXACILLIN; PETROLATUM; TACROLIMUS;

ABDOMINAL PAIN; ADOLESCENT; ANTIBIOTIC SENSITIVITY; ANTIBODY TITER; ARTICLE; ATOPIC DERMATITIS; BLEACHING; CHILD; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG MEGADOSE; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EOSINOPHILIA; ERYTHRODERMA; FACE; FEMALE; FINGER; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW UP; GLUCOSE TOLERANCE TEST; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPETIC STOMATITIS; HUMAN; ICHTHYOSIS VULGARIS; IMMUNOFLUORESCENCE; KAPOSI VARICELLIFORM ERUPTION; LEUKOCYTE COUNT; MALE; NAUSEA; NOSE CONGESTION; PATCH TEST; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PUSTULE; SCHOOL CHILD; SKIN ATROPHY; SKIN BIOPSY; SKIN CARE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS GROUP A; THROAT CULTURE; VIRUS CULTURE;

2-AMINOPURINE; ACYCLOVIR; ADOLESCENT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; FEMALE; HERPES SIMPLEX; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INTERFERON-GAMMA; KAPOSI VARICELLIFORM ERUPTION; MALE; METHOTREXATE; PATCH TESTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 79551564822     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2010.01356.x     Document Type: Article

References (38)

1. Schmitt J, Schakel K, Schmitt N, et al. Systemic treatment of severe atopic eczema: a systemic review. Acta Derm Venereol 2007; 87: 100-111.
2. Wichmann K, Uter W, Weiss J, et al. Isolations of α-toxin-producing Staphylococcus aureus from the skin of highly sensitized adult patients with severe atopic dermatitis. Br J Dermatol 2009; 161: 300-305.
3. Howell M, Wollenberg A, Gallo R, et al. Cathelicidin deficiency predisposes to eczema herpeticum. J Allergy Clin Immunol 2006; 117: 836-841.
4. Boguniewicz M, Schmid-Grendelmeier P, Leung D,. Atopic dermatitis. J Allergy Clin Immunol 2006; 118: 40-43.
5. Lubbe J,. Adults with atopic dermatitis and herpes simplex and topical therapy with tacrolimus: what kind of prevention? Arch Dermatol 2003; 139: 670-671.
6. Nahass GT, Goldstein BA, Zhu WY, et al. Comparison of Tzanck smear, viral culture, and DNA diagnostic methods in detection of herpes simplex and varicella-zoster infection. JAMA 1992; 268: 2541-2544.
7. Ozcan A, Senol M, Saglam H, et al. Comparison of the Tzanck test and polymerase chain reaction in the diagnosis of cutaneous herpes simplex and varicella zoster virus infections. Int J Dermatol 2007; 46: 1177-1179.
8. Leach CT, Ashley RL, Baillargeon J, et al. Performance of two commercial glycoprotein G-based enzyme immunoassays for detecting antibodies to herpes simplex viruses 1 and 2 in children and young adolescents. Clin Diagn Lab Immunol 2002; 9: 1124-1125.
9. Lennette EH, ed. Laboratory diagnosis of viral infections. New York: Marcel Dekker, Inc., 1999:494.
10. Xu F, Lee FK, Morrow RA, et al. Seroprevalence of herpes simplex virus type 1 in children in the United States. J Pediatr 2007; 151: 374-377.
11. Cohen PR,. Tests for detecting herpes simplex virus and varicella-zoster virus infections. Dermatol Clin 1994; 12: 51-68.
12. Spruance SL, Overall JC, Kern ER, et al. The natural history of recurrent herpes simplex labialis. N Engl J Med 1977; 297: 69.
13. Zirn JR, Tompkins SD, Huie C, Shea CR,. Rapid detection and distinction of cutaneous herpesvirus infections by direct immunofluorescence. J Am Acad Dermatol 1995; 33: 724-728.
14. Bezold G, Lange M, Gethoffer K, et al. Detection of cutaneous herpes simplex virus infections by immunofluorescence vs PCR. J Eur Acad Dermatol Venereol 2003; 17: 430-433.
15. Lipson SM, Salo RJ, Leonardi GP,. Evaluation of five monoclonal antibody-based kits or reagents for the identification and culture confirmation of herpes simplex virus. J Clin Microbiol 1991; 29: 466-469.
16. Jain S, Wyatt D, McCaughey C, et al. Nested multiplex polymerase chain reaction for the diagnosis of cutaneous herpes simplex and herpes zoster infections and a comparison with electronmicroscopy. J Med Virol 2001; 63: 52-56.
17. Kimata H,. Rapidly increasing incidence of Kaposi's varicelliform eruption in patients with atopic dermatitis. Indian J Dermatol Venereol Leprol 2008; 74: 260-261.
18. Koo J, Fleischer A Jr, Abramovits W, et al. Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: results in 8000 patients. J Am Acad Dermatol 2005; 53: S195-S205.
19. Borchard K, Orchard D,. Systemic therapy of paediatric atopic dermatitis: an update. Aust J Dermatol 2008; 49: 123-136.
20. Harper JI, Barclay G, Lacour M, et al. Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy. Br J Dermatol 2000; 142: 52-58.
21. Weatherhead SC, Wahie S, Reynolds NJ, et al. An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema. Br J Dermatol 2007; 156: 346-351.
22. Minjeong K, Minyoung J, Seung-Phil H, et al. Topical calcineurin inhibitors compromise stratum corneum integrity, epidermal permeability and antimicrobial barrier function. Exp Dermatol 2009.
23. Wetzel S, Wollenberg A,. Eczema molluscatum in tacrolimus treated atopic dermatitis. Eur J Dermatol 2004; 14: 73-74.
24. Patrizi A,. Facial eruption of viral warts in a child treated with 0.03% tacrolimus ointment for atopic dermatitis. Pediatr Dermatol 2007; 24: 445-446.
25. Kimata H,. Kaposi's varicelliform eruption associated with the use of tacrolimus. Indian J Dermatol Venereol Leprol 2008; 74: 262-263.
26. Ulrich W, Bos JD, Goodfield M, et al. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. Pediatrics 2002; 110: e2.
27. Yeung-Yue KA, Brentjens MH, Lee PC, et al. Herpes simplex virus 1 and 2. Dermatol Clin 2002; 20: 249-266.
28. Wollenberg A, Zoch C, Wetzel S, et al. Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases. J Am Acad Dermatol 2003; 49: 198-205.
29. Hata TR, Gallo RL,. Antimicrobial peptides, skin infections and atopic dermatitis. Semin Cutan Med Surg 2008; 27: 144-150.
30. He R, Geha RS,. Thymic stromal lymphopoietin. Ann NY Acad Sci 2010; 1183: 13-24.
31. Zhang Q, Davis JC, Lamborn IT, et al. Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med 2009; 361: 2046-2055.
32. Erlich K,. Topics in primary care medicine: management of herpes simplex and varicella-zoster virus infections. West J Med 1997; 166: 211-215.
33. Cassady KA, Whitley RJ,. New therapeutic approaches to the alpha herpesvirus infections. J Antimicrob Chemother 1997; 39: 119-128.
34. Chang TT, Stevens SR,. Atopic dermatitis: the role of recombinant interferon-γ therapy. Am J Clin Dermatol 2002; 3: 175-183.
35. Hanifen JM, Schneider LC, Leung DY, et al. Recombinant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol 1993; 1: 187-197.
36. Jang I, Yang J, Lee H, et al. Clinical improvement and immunohistochemical findings in severe atopic dermatitis treated with interferon gamma. J Am Acad Dermatol 2000; 42: 1033-1040.
37. Noh G, Lee KY,. Intravenous immune globulin (IVIG) therapy in steroid-resistant atopic dermatitis. J Korean Med Sci 1999; 14: 63-68.
38. Jolles S,. A review of high-dose intravenous immunoglobulin treatment for atopic dermatitis. Clin Exp Dermatol 2002; 27: 3-7.